Alps Advisors Inc Biogen Inc. Transaction History

Alps Advisors Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $2,752 - $3,180	10 Added 0.81%	1,240 $353,000
Q1 2023 May 10, 2023	BUY	$256.56 - $292.34 $315,568 - $359,578	1,230 New	1,230 $341,000
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $186,752 - $247,321	-722 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$268.85 - $341.04 $200,024 - $253,733	-744 Reduced 50.75%	722 $228,000
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $13,863 - $19,156	-63 Reduced 4.12%	1,466 $435,000
Q3 2019 Nov 04, 2019	BUY	$217.44 - $243.88 $66,319 - $74,383	305 Added 24.92%	1,529 $356,000
Q2 2019 Aug 07, 2019	SELL	$219.29 - $241.72 $68,637 - $75,658	-313 Reduced 20.36%	1,224 $286,000
Q1 2019 May 01, 2019	SELL	$216.71 - $338.96 $1.55 Million - $2.42 Million	-7,153 Reduced 82.31%	1,537 $363,000
Q4 2018 Feb 04, 2019	BUY	$278.5 - $352.75 $882,009 - $1.12 Million	3,167 Added 57.34%	8,690 $2.62 Million
Q3 2018 Oct 25, 2018	BUY	$293.51 - $383.83 $1.07 Million - $1.4 Million	3,638 Added 193.0%	5,523 $1.95 Million
Q2 2018 Aug 02, 2018	BUY	$257.52 - $306.91 $21,374 - $25,473	83 Added 4.61%	1,885 $547,000
Q2 2018 Jul 25, 2018	SELL	$257.52 - $306.91 $112,021 - $133,505	-435 Reduced 19.45%	1,802 $574,000
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $113,156 - $160,040	435 Added 24.14%	2,237 $613,000
Q4 2017 Feb 05, 2018	SELL	$307.64 - $344.58 $60,912 - $68,226	-198 Reduced 9.9%	1,802 $574,000
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $562,300 - $659,380	2,000	2,000 $626,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.